Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender

被引:26
作者
Eckstein, F
Lochmüller, EM
Koller, B
Wehr, U
Weusten, A
Rambeck, W
Hoeflich, A
Wolf, E
机构
[1] Univ Munich, Anat Anstalt, Musculoskeletal Res Grp, D-80336 Munich, Germany
[2] Univ Munich, Frauenklin 1, D-80337 Munich, Germany
[3] Scanco Med, Bassersdorf, Switzerland
[4] Univ Munich, Inst Physiol Physiol Chem & Anim Nutr, D-80539 Munich, Germany
[5] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Gene Ctr, D-81377 Munich, Germany
关键词
growth hormone; transgenic animal model; mouse; dual-energy X-ray absorptiometry; bone microstructure; trabecular bone;
D O I
10.1054/ghir.2002.0272
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Experimental and clinical studies suggest that high serum levels of growth hormone (GH) increase cortical but not trabecular bone. We studied body composition and bone structure in transgenic mice (MT-bGH) with systemic overexpression of GH. Body composition was examined with dual-energy X-ray absorptionnetry (DXA), ashing, and chemical analysis, and the femora with DXA and micro computerized tomography. The absolute fat and bone tissue contents were significantly higher in GH transgenic mice vs controls (P < 0.05), but no significant difference was noted when normalizing the values to body weight. Male transgenics displayed no change in apparent (volumetric) femoral bone density, relative cortical area and trabecular bone volume fraction. Female transgenic mice demonstrated an increase in apparent femoral density and in trabecular bone volume fraction (+130%; P < 0.01). The mineralized tissue matrix density was decreased in male and female transgenic mice (P < 0.05). The results show that chronic GH excess affects trabecular bone in a gender-specific manner and that bone changes depend on the compartment investigated. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:116 / 125
页数:10
相关论文
共 53 条
[1]  
Andreassen TT, 1996, J BONE MINER RES, V11, P1094
[2]  
ANDREASSEN TT, 1995, J BONE MINER RES, V10, P1057
[3]   Effects of 22K or 20K human growth hormone on lipolysis, leptin production in adipocytes in the presence and absence of human growth hormone binding protein [J].
Asada, N ;
Takahashi, Y ;
Honjo, M .
HORMONE RESEARCH, 2000, 54 (04) :203-207
[4]  
Beamer WG, 2000, GROWTH HORM IGF RES, V10, P103
[5]   The use of growth hormone in adults: a review of the last 10 years, the present and a perspective for the future [J].
Bengtsson, BA ;
Johannsson, G .
GROWTH HORMONE & IGF RESEARCH, 1998, 8 :27-35
[6]   Axial bone mineral density in patients with acromegaly [J].
Bolanowski, M ;
Wielgus, W ;
Milewicz, A ;
Marciniak, R .
ACADEMIC RADIOLOGY, 2000, 7 (08) :592-594
[7]  
BREM G, 1989, MOL BIOL MED, V6, P531
[8]   Effects of growth hormone on body composition and bone metabolism [J].
Carrel, AL ;
Allen, DB .
ENDOCRINE, 2000, 12 (02) :163-172
[9]   A non-destructive technique for 3-D microstructural phenotypic characterisation of bones in genetically altered mice:: preliminary data in growth hormone transgenic animals and normal controls [J].
Graichen, H ;
Lochmüller, EM ;
Wolf, E ;
Langkabel, B ;
Stammberger, T ;
Haubner, M ;
Renner-Müller, I ;
Englmeier, KH ;
Eckstein, F .
ANATOMY AND EMBRYOLOGY, 1999, 199 (03) :239-248
[10]   ILIAC CREST BONE MASS AND REMODELING IN ACROMEGALY [J].
HALSE, J ;
MELSEN, F ;
MOSEKILDE, L .
ACTA ENDOCRINOLOGICA, 1981, 97 (01) :18-22